Trial Profile
Prospective study comparing the efficacy of Abatacept against other biologic DMARDs in treatment of patients with rheumatoid arthritis from BRASS registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 10 Feb 2016 New trial record